AVIR - Atea Pharmaceuticals Q2 2022 Earnings Preview
- Atea Pharmaceuticals ( NASDAQ: AVIR ) is scheduled to announce Q2 earnings results on Monday, August 8th, after market close.
- The consensus EPS Estimate is -$0.49 (-2550.0% Y/Y) and the consensus Revenue Estimate is $0M
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 1 downward.
For further details see:
Atea Pharmaceuticals Q2 2022 Earnings Preview